Document is current

Hrdinka, Matous https://orcid.org/0000-0002-2981-2825

Schlicher, Lisa

Dai, Bing

Pinkas, Daniel M

Bufton, Joshua C

Picaud, Sarah

Ward, Jennifer A

Rogers, Catherine

Suebsuwong, Chalada

Nikhar, Sameer

Cuny, Gregory D

Huber, Kilian VM https://orcid.org/0000-0002-1103-5300

Filippakopoulos, Panagis

Bullock, Alex N

Degterev, Alexei https://orcid.org/0000-0002-8240-7132

Gyrd‐Hansen, Mads https://orcid.org/0000-0001-5641-5019

Funding for this research was provided by:

UNC | UNC‐CH | Eshelman Institute for Innovation, University of North Carolina at Chapel Hill

Merck KGaA | Allergopharma

Novartis | Novartis Pharma

Wellcome Trust (106169/ZZ14/Z)

Wellcome Trust (095751/Z/11/Z)

Wellcome Trust (102894/Z/13/Z)

Takeda Pharmaceutical Company

Ministry of Higher Education and Science | Forskerakademiet

Ministerstvo Vnitra České Republiky (18‐24070Y)

European Molecular Biology Organization

Ludwig Institute for Cancer Research Ltd

AbbVie

Bayer Pharma AG

Boehringer Ingelheim

Canada Foundation for Innovation

Genome Canada

Innovative Medicines Initiative (ULTRA‐DD 115766)

Janssen

MSD

Ontario Ministry of Economic Development and Innovation

Pfizer

São Paulo Research Foundation‐FAPESP

Myeloma UK

American Heart Association (15GRNT22970025)

NIH (R01CA190542)

NIH (R21AI124049)

Text and Data Mining valid from 2018-07-19

Version of Record valid from 2018-07-19